AZN — AstraZeneca Share News

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Market Cap
£198.21bn
Enterprise Value
£217.54bn
Revenue
$54.07bn

REG - AstraZeneca PLC - EMA accepts Tagrisso submission for 1st-line nsclc <Origin Href="QuoteRef">AZN.L</Origin>
28/11/2017 07:05Announcement
REG - AstraZeneca PLC - AZ submits Tagrisso in Japan for 1st-line nsclc <Origin Href="QuoteRef">AZN.L</Origin>
27/11/2017 07:05Announcement
REG - AstraZeneca PLC - AZ Fasenra receives FDA approval for severe asthma <Origin Href="QuoteRef">AZN.L</Origin>
15/11/2017 07:00Announcement
REG - AstraZeneca PLC - BENRALIZUMAB POSITIVE CHMP IN EOSINOPHILIC ASTHMA <Origin Href="QuoteRef">AZN.L</Origin>
10/11/2017 11:36Announcement
REG - AstraZeneca PLC - AZN: Year-To-Date and Q3 2017 Results Announcement <Origin Href="QuoteRef">AZN.L</Origin> - Part 4
09/11/2017 07:08Announcement
REG - AstraZeneca PLC - AZN: Year-To-Date and Q3 2017 Results Announcement <Origin Href="QuoteRef">AZN.L</Origin> - Part 5
09/11/2017 07:08Announcement
REG - AstraZeneca PLC - AZN: Year-To-Date and Q3 2017 Results Announcement <Origin Href="QuoteRef">AZN.L</Origin> - Part 2
09/11/2017 07:08Announcement
REG - AstraZeneca PLC - AZN: Year-To-Date and Q3 2017 Results Announcement <Origin Href="QuoteRef">AZN.L</Origin> - Part 1
09/11/2017 07:07Announcement
REG - AstraZeneca PLC - AZN: Year-To-Date and Q3 2017 Results Announcement <Origin Href="QuoteRef">AZN.L</Origin> - Part 3
09/11/2017 07:07Announcement
REG - AstraZeneca PLC - Total Voting Rights <Origin Href="QuoteRef">AZN.L</Origin>
01/11/2017 15:01Announcement
REG - AstraZeneca PLC - ASTRAZENECA AND ASPEN COMPLETE ANAESTHETICS DEAL <Origin Href="QuoteRef">AZN.L</Origin>
01/11/2017 07:06Announcement
REG - AstraZeneca PLC - AstraZeneca tralokinumab update in severe asthma <Origin Href="QuoteRef">AZN.L</Origin>
01/11/2017 07:01Announcement
REG - AstraZeneca PLC - US FDA approves AstraZeneca's Calquence for MCL <Origin Href="QuoteRef">AZN.L</Origin>
31/10/2017 17:06Announcement
REG - AstraZeneca PLC - AZ and MSD rapidly advance Lynparza in Japan <Origin Href="QuoteRef">AZN.L</Origin>
23/10/2017 07:10Announcement
REG - AstraZeneca PLC - US FDA approves Bydureon BCise for type-2 diabetes <Origin Href="QuoteRef">AZN.L</Origin>
23/10/2017 07:01Announcement
REG - AstraZeneca PLC - FDA Priority Review for Lynparza in breast cancer <Origin Href="QuoteRef">AZN.L</Origin>
18/10/2017 07:01Announcement
REG - AstraZeneca PLC - FDA accepts sBLA file for Imfinzi; priority review <Origin Href="QuoteRef">AZN.L</Origin>
17/10/2017 07:01Announcement
REG - AstraZeneca PLC - FDA grants Tagrisso BTD for 1st-line EGFR nsclc <Origin Href="QuoteRef">AZN.L</Origin>
09/10/2017 07:01Announcement
REG - AstraZeneca PLC - Total Voting Rights <Origin Href="QuoteRef">AZN.L</Origin>
02/10/2017 15:00Announcement
REG - AstraZeneca PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">AZN.L</Origin>
26/09/2017 12:01Announcement